AmerisourceBergen could exceed the symbolic threshold of USD 70.9.
Regarding the fundamentals, we note the increase of sales recorded over the previous year. For the year 2014, profits are expected to double compared to 2013. The valuation of the group remains fair and analysts are still positive on the security.
Since several months, the stock has initiated a sharp bullish trend mainly due to strong fundamentals. The move could be continued, supported by the 20-day moving average, and return to its highest price levels. The crossing of the USD 70.9 resistance should drive prices toward the trendline around USD 74.
Exceeding the technical line at USD 70.9 would give ambitious upward targets. In this case, market participants could buy this stock with an initial target of USD 74. Once the position in the portfolio, a stop loss should be placed under the entry point.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
CENCORA, INC. 
